A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, hospital Tengku Ampuan Rahimah, Selangor, Malaysia

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 32, Issue 6, 2010, Pages 427-432

  Ponto, T ^a   Ismail, N I ^a   Abdul Majeed, A B ^a   Marmaya, N H ^a   Zakaria, Z A ^b  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPIN 2 ONE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; FLUPENTIXOL DECANOATE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE; VALPROIC ACID; ZUCLOPENTHIXOL; ZUCLOPENTHIXOL DECANOATE; NEUROLEPTIC AGENT;

ADULT; AGE; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CHINESE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MONOTHERAPY; OUTPATIENT CARE; PHARMACY; PRESCRIPTION; SCHIZOPHRENIA; ADOLESCENT; CLINICAL PRACTICE; DOSE RESPONSE; HOSPITAL PHARMACY; MIDDLE AGED; PRACTICE GUIDELINE; PROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79952110140     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2010.32.6.1477907     Document Type: Article

References (25)

1. Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, J., Hsiao, J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005, 353(12): 1209-23.
2. Bebbington, P., Freemantle, N., Harrison, P., Geddes, J. Atypical antipsychotics in the treatment of schizophrenia: systematic review and metaregression analysis. Br Med J 2001, 321(7273): 1371-6.
3. Rittmannsberger, H., Meise, U., Schauflinger, K., Horvath, E., Donat, H., Hinterhuber, H. Polypharmacy in psychiatric treatment. Patterns of psychotic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999, 14(1): 33-40.
4. Frye, M., Ketter, T., Leverich, G., Huggins, T., Lantz,C., Denicoff, K.D., Post, M. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000, 61(1): 9-15.
5. Mccue, R.E., Waheed, R., Urcuo, L. Polypharmacy in patients with schizophrenia. J Clin Psychiatry 2003, 64(9): 984-9.
6. Takei, N., Inagaki, A. Polypharmacy for psychiatric treatments in Japan. Lancet 2002, 360(9333): 647.
7. Covell, N.H., Jackson, C.T, Evans, A.C., Essock, S.M. Antipsychotic prescribing practices in Connecticut"s public mental health system: Rates of changing medications and prescribing styles. Schizophrenia Bull 2002, 28(1): 17-29.
8. Padmini, D.D., Amarjeeth, R., Sushma, M., Guido, S. Prescription patterns of psychotic drugs in hospitalized schizophrenic patients in a tertiary care hospital. Calicut Med J 2007, 5(4): e3.
9. Yusof, Y.B., Ab. Rahman, A.F., Efendie, B. Drug prescribing pattern in patients with schizophrenia attending the psychiatric outpatient clinic of Hospital Pulau Pinang. Mal J Psychiatry 2004, 12(2): 38-43.
10. Lehman, A.F., Steinwachs, D.M. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations. Schizophrenia Bull 1998, 24(1): 1-10.
11. Casey, D.E., Daniel, D.G., Wassef, A.A., Tracy, K.A., Wozniak, P., Sommerville, K.W. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacol 2003, 28(1): 182-92.
12. Koranyi, E.K. Undiagnosed Physical illness in Psychiatric Patients. Ann Rev Med 1982, 33: 309-316.
13. Ndetei, D.M., Khasakhala, L.I., Kuria, M.W., Mutiso, V.N., Ongecha-Owuor, F.A., Kokonya, D.A. The prevalence of mental disorders in adults in different level general medical facilities in Kenya: a cross-sectional study. Ann Gen Psychiatry 2009, 8: 1.
14. Glick, I.D. Undiagnosed bipolar disorder: New syndromes and new treatments. Prim Care Companion J Clin Psychiatry 2004, 6(1): 27-33.
15. Tidemalm, D., Waern, M., Stefansson, C-G., Elofsson, S. Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12103 individuals with and without contact with psychiatric services. Clin Pract Epidemiol Ment Health 2008, 4: 23.
16. McCombs, J.S., Nichol, M.B., Stimmel, G.L., Shi, J., Smith, R.R. Use patterns for antipsychotic medications in Medicaid patients with Schizophrenia. J Clin Psychiatry 1999, 60(Suppl 19): 5-11.
17. McCauley, M., Connolly, G. Evidence for the use of depot neuroleptic medication. Ir J Psych Med 2004, 21(3): 95-9.
18. Davis, J.M., Andriukaitis, S. The natural course of schizophrenia and effective maintenance drug treatment. J Clin Psychopharm 1986, 6(Suppl 1): 2S-10S.
19. Baldessarini, R.J., Kando, J.C., Centorrino, F. Hospital use of antipsychotic agents in 1989 and 1993: Stable dosing with decreased length of stay. Am J Psychiatry 1995, 152: 1038-44.
20. Keks, N.A., Altson, K., Hope, J., Krapivensky, N., Culhane, C. Use of Antipsychosis and Adjunctive Medications by an Inner Urban Community Psychiatric Service. Aust New Zeal J Psychiatry 1999, 33(6): 896-901.
21. Chong, S.A., Sachdev, P., Mahendran, R., Chua, H.C. Neuroleptic and anticholinergic drug use in chinese patients with schizophrenia resident in a state psychiatric Hospital in Singapore. Aust New Zeal J Psychiatry 2000, 34(6): 988-91.
22. Magliano, L., Fiorillo, A., Guarneri, M., Marasco, C., De Rosa, C., Malangone, C., et al. (2004). Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey. Eur J Clin Pharmacol 2004, 60(7): 513-22.
23. Bitter, I., Treuer, T., Dyachkova, Y., Martenyi, F., McBride, M., Ungvari, G.S. Antipsychotic prescription pattern in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. European Neuropsychopharmacol 2008, 18(3): 170-80.
24. Holloway, F. Prescribing for the long term mentally ill. A study of treatment practices. Br J Psychiatry 1988, 152(4): 511-5.
25. Kidon, M.I., See, Y. Adverse drug reactions in Singapore children. Singapore Med J 2004, 45(12): 574-7.